|
1
|
Pincus T: Long-term outcomes in rheumatoid
arthritis. Br J Rheumatol. 34:(Suppl 2). S59–S73. 1995. View Article : Google Scholar
|
|
2
|
Kay J and Calabrese L: The role of
interleukin-1 in the pathogenesis of rheumatoid arthritis.
Rheumatology (Oxford). 43:(Suppl 3). iii2–iii9. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Burrage PS, Mix KS and Brinckerhoff CE:
Matrix metalloproteinases: Role in arthritis. Front Biosci.
11:529–543. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hogquist KA, Nett MA, Unanue ER and
Chaplin DD: Interleukin 1 is processed and released during
apoptosis. Proc Natl Acad Sci USA. 88:8485–8489. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Vignon E, Arlot M and Vignon G: Cellular
density of the femur head cartilage in relation to age. Rev Rhum
Mal Osteoartic. 43:403–405. 1976.PubMed/NCBI
|
|
6
|
Marx RE: Platelet-rich plasma: Evidence to
support its use. J Oral Maxillofac Surg. 62:489–496. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hall MP, Band PA, Meislin RJ, Jazrawi LM
and Cardone DA: Platelet-rich plasma: Current concepts and
application in sports medicine. J Am Acad Orthop Surg. 17:602–608.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sánchez M, Anitua E, Orive G, Mujika I and
Andia I: Platelet-rich therapies in the treatment of orthopaedic
sport injuries. Sports Med. 39:345–354. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Eppley BL, Pietrzak WS and Blanton M:
Platelet-rich plasma: A review of biology and applications in
plastic surgery. Plast Reconstr Surg. 118:147e–159e. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Foster TE, Puskas BL, Mandelbaum BR,
Gerhardt MB and Rodeo SA: Platelet-rich plasma: From basic science
to clinical applications. Am J Sports Med. 37:2259–2272. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Redler LH, Thompson SA, Hsu SH, Ahmad CS
and Levine WN: Platelet-rich plasma therapy: A systematic
literature review and evidence for clinical use. Phys Sportsmed.
39:42–51. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Margolis DJ, Kantor J, Santanna J, Strom
BL and Berlin JA: Effectiveness of platelet releasate for the
treatment of diabetic neuropathic foot ulcers. Diabetes Care.
24:483–488. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Martínez-Zapata MJ, Martí-Carvajal A, Solà
I, Bolibar I, Angel Expósito J, Rodriguez L and García J: Efficacy
and safety of the use of autologous plasma rich in platelets for
tissue regeneration: A systematic review. Transfusion. 49:44–56.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sclafani AP: Applications of platelet-rich
fibrin matrix in facial plastic surgery. Facial Plast Surg.
25:270–276. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Albano JJ and Alexander RW: Autologous fat
grafting as a mesenchymal stem cell source and living bioscaffold
in a patellar tendon tear. Clin J Sport Med. 21:359–361. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cervelli V, Gentile P, Scioli MG, Grimaldi
M, Casciani CU, Spagnoli LG and Orlandi A: Application of
platelet-rich plasma in plastic surgery: Clinical and in vitro
evaluation. Tissue Eng Part C Methods. 15:625–634. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Akeda K, An HS, Okuma M, Attawia M,
Miyamoto K, Thonar EJ, Lenz ME, Sah RL and Masuda K: Platelet-rich
plasma stimulates porcine articular chondrocyte proliferation and
matrix biosynthesis. Osteoarthritis Cartilage. 14:1272–1280. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xie X, Zhang C and Tuan RS: Biology of
platelet-rich plasma and its clinical application in cartilage
repair. Arthritis Res Ther. 16:2042014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
van Buul GM, Koevoet WL, Kops N, Bos PK,
Verhaar JA, Weinans H, Bernsen MR and van Osch GJ: Platelet-rich
plasma releasate inhibits inflammatory processes in osteoarthritic
chondrocytes. Am J Sports Med. 39:2362–2370. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Assirelli E, Pulsatelli L, Dolzani P,
Platano D, Olivotto E, Filardo G, Trisolino G, Facchini A, Borzì RM
and Meliconi R: Human osteoarthritic cartilage shows reduced in
vivo expression of IL-4, a chondroprotective cytokine that
differentially modulates IL-1β-stimulated production of chemokines
and matrix-degrading enzymes in vitro. PLoS One. 9:e969252014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mobasheri A and Shakibaei M: Is tendinitis
an inflammatory disease initiated and driven by pro-inflammatory
cytokines such as interleukin 1β? Histol Histopathol. 28:955–964.
2013.PubMed/NCBI
|
|
23
|
Nikoletopoulou V, Markaki M, Palikaras K
and Tavernarakis N: Crosstalk between apoptosis, necrosis and
autophagy. Biochim Biophys Acta. 1833:3448–3459. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang X, Xu X, Xu T and Qin S:
β-Ecdysterone suppresses interleukin-1β-induced apoptosis and
inflammation in rat chondrocytes via inhibition of NF-κB signaling
pathway. Drug Dev Res. 75:195–201. 2014.PubMed/NCBI
|
|
25
|
Sena P, Manfredini G, Benincasa M, Mariani
F, Smargiassi A, Catani F and Palumbo C: Up-regulation of the
chemo-attractive receptor ChemR23 and occurrence of apoptosis in
human chondrocytes isolated from fractured calcaneal osteochondral
fragments. J Anat. 224:659–668. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Minashima T, Campbell KA, Hadley SR, Zhang
Y and Kirsch T: The role of ANK interactions with MYBBP1a and SPHK1
in catabolic events of articular chondrocytes. Osteoarthritis
Cartilage. 22:852–861. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Williams A, Smith JR, Allaway D, Harris P,
Liddell S and Mobasheri A: Carprofen inhibits the release of matrix
metalloproteinases 1, 3 and 13 in the secretome of an explant model
of articular cartilage stimulated with interleukin 1β. Arthritis
Res Ther. 15:R2232013. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Attur MG, Dave MN, Leung MY, Cipolletta C,
Meseck M, Woo SL and Amin AR: Functional genomic analysis of type
II IL-1beta decoy receptor: Potential for gene therapy in human
arthritis and inflammation. J Immunol. 168:2001–2010. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tsutsumi R, Ito H, Hiramitsu T, Nishitani
K, Akiyoshi M, Kitaori T, Yasuda T and Nakamura T: Celecoxib
inhibits production of MMP and NO via down-regulation of NF-kappaB
and JNK in a PGE2 independent manner in human articular
chondrocytes. Rheumatol Int. 28:727–736. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bacconnier L, Jorgensen C and Fabre S:
Erosive osteoarthritis of the hand: Clinical experience with
anakinra. Ann Rheum Dis. 68:1078–1079. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chevalier X, Goupille P, Beaulieu AD,
Burch FX, Bensen WG, Conrozier T, Loeuille D, Kivitz AJ, Silver D
and Appleton BE: Intraarticular injection of anakinra in
osteoarthritis of the knee: A multicenter, randomized,
double-blind, placebo-controlled study. Arthritis Rheum.
61:344–352. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Amable PR, Carias RB, Teixeira MV, da Cruz
Pacheco I, Corrêa do Amaral RJ, Granjeiro JM and Borojevic R:
Platelet-rich plasma preparation for regenerative medicine:
Optimization and quantification of cytokines and growth factors.
Stem Cell Res Ther. 4:672013. View
Article : Google Scholar : PubMed/NCBI
|
